1400P Vibostolimab, an anti-TIGIT antibody, as monotherapy and in combination with pembrolizumab in anti-PD-1/PD-L1-refractory NSCLCM-J. Ahn,J. Niu,D-W. Kim,D. Rasco, K.F. Mileham,H.C. Chung, U.N. Vaishampayan,C. Maurice-Dror,P. Lo Russo,T. Golan, E. Chartash,D. Chen,J. Healy, M. Rajasagi,D.H. LeeAnnals of Oncology(2020)引用 25|浏览42暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要